Stopped early
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
NCT03824808 · University of Missouri-Columbia · Updated 25 Oct 2023
- What is being tested
- Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution; 0.9% Sodium Chloride Injection
- For
- Kidney Cancer; Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years and older. About 21 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 26 Feb 2019, ends 26 March 2020. Registered 31 Jan 2019.
- Results
- Posted on the registry on 25 Oct 2023.
In the researchers' words
Controlling pain is fundamental during and after surgical procedures. This study examines pain associated with robotic assisted surgery on prostate cancer or a kidney mass. In recent years, the risk of opioids in the postoperative period has gained interest due to the growing epidemic of addiction, dependence, and overdose. In this study, the investigators expect a continuous infusion of intravenous lidocaine during the perioperative period to result in less pain and less opioid use.
Sites
- University HospitalColumbia, Missouri, United States